ARCHIVES

Full Funding Of Indirect Costs, Other Mandates By Congress Chew Up Most Of NCI’s Extra Money

This article is from The Cancer Letter archive.

Vol. 09 No. 46 | December 2, 1983

Download PDF Visit The Full Archive

Related Articles

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010

FDA Approves Treatment For Late-Stage Cervical Cancer

June 30, 2006

Clinical Research Group Of ACCC Meets

April 24, 1981

Biomedical Science Leadership is America’s Greatest Contribution, Benno Schmidt Says

August 14, 1987

In Brief: Budget Resolution Calls For 1% Cut In NIH, Then Six Years At 3% Below Current Budget

July 7, 1995

NCI Implementing Changes In Organ Site Program, Directing Grant applications To NIH Study Sections

October 15, 1982